BlackRock’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
561,848
-897,328
| -61% | -$1.97M | ﹤0.01% | 4119 |
|
|
2025
Q1 | $3.15M | Sell |
1,459,176
-20,838
| -1% | -$45K | ﹤0.01% | 3791 |
|
|
2024
Q4 | $6.26M | Buy |
1,480,014
+34,280
| +2% | +$145K | ﹤0.01% | 3588 |
|
|
2024
Q3 | $16.5M | Buy |
1,445,734
+874,810
| +153% | +$10M | ﹤0.01% | 3120 |
|
|
2024
Q2 | $6.1M | Buy |
570,924
+429,356
| +303% | +$4.59M | ﹤0.01% | 3568 |
|
|
2024
Q1 | $2.17M | Buy |
+141,568
| New | +$2.17M | ﹤0.01% | 3919 |
|